Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia, Vascular | 3 | 2022 | 22 | 1.790 |
Why?
|
| White Matter | 2 | 2022 | 174 | 1.310 |
Why?
|
| Cognitive Dysfunction | 2 | 2022 | 176 | 1.270 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2022 | 195 | 1.080 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 19 | 0.650 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2018 | 73 | 0.630 |
Why?
|
| Dipeptides | 1 | 2018 | 89 | 0.630 |
Why?
|
| Chemokines | 1 | 2018 | 119 | 0.620 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 124 | 0.610 |
Why?
|
| Cytokines | 1 | 2018 | 866 | 0.470 |
Why?
|
| Rats | 5 | 2022 | 5300 | 0.300 |
Why?
|
| Neurovascular Coupling | 1 | 2020 | 9 | 0.190 |
Why?
|
| Peptide Hormones | 1 | 2020 | 9 | 0.180 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2020 | 35 | 0.180 |
Why?
|
| Neuroprotection | 1 | 2020 | 28 | 0.180 |
Why?
|
| Triazines | 1 | 2020 | 48 | 0.180 |
Why?
|
| Parkinsonian Disorders | 1 | 2020 | 43 | 0.170 |
Why?
|
| Rats, Wistar | 1 | 2020 | 371 | 0.170 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 79 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2022 | 384 | 0.170 |
Why?
|
| Microglia | 1 | 2020 | 143 | 0.170 |
Why?
|
| Benzamides | 1 | 2020 | 156 | 0.170 |
Why?
|
| Calpain | 1 | 2020 | 205 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 244 | 0.160 |
Why?
|
| Animals | 5 | 2022 | 20880 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 226 | 0.160 |
Why?
|
| Gene Expression | 1 | 2018 | 770 | 0.130 |
Why?
|
| Brain | 2 | 2022 | 2176 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 551 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2222 | 0.110 |
Why?
|
| Male | 5 | 2022 | 37283 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 2162 | 0.090 |
Why?
|
| Hemin | 1 | 2022 | 10 | 0.050 |
Why?
|
| Deferoxamine | 1 | 2022 | 45 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2022 | 35 | 0.050 |
Why?
|
| Female | 2 | 2022 | 38021 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2022 | 122 | 0.050 |
Why?
|
| Middle Aged | 1 | 2018 | 21119 | 0.050 |
Why?
|
| Hormones | 1 | 2020 | 42 | 0.050 |
Why?
|
| Thoracic Vertebrae | 1 | 2020 | 52 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 126 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 203 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 397 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 506 | 0.040 |
Why?
|
| Humans | 2 | 2022 | 68549 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 2083 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 2791 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 2550 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 8474 | 0.020 |
Why?
|